A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017 A(H7N9) Inactivated Influenza Virus Vaccines Administered With and Without AS03 Adjuvant in Healthy US Adults is a research paper published in Clinical Infectious Diseases (2024). On theSindex it has a DataRank of 0.384. It has been cited 11 times, with 5 citing works in its 1-hop citation network.
Scored on demand from live citation data
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.373
From this paper's citation signal
Citation Network Contribution
0.0111
From 1 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 5 citers.
National Institutes of Health
Grant: HHSN272201300018I
National Institutes of Health
Grant: UL1 TR002537
Emory
Grant: HHSN272201300015I
Baylor College of Medicine
Grant: HHSN272201300020I
University of Iowa
Grant: HHSN27220130021I
Saint Louis University
Grant: HHSN2722013000017I
BARDA
Grant: HHSO100201600004I
BARDA
Grant: HHSO100201600006I
FWCI
3.17
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals